Figure 1From: Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell Carcinoma: a prospective evaluation CT scans for a patient of a patient with bilateral disseminated pulmonary metastasesshowing a partial response on sorafenib treatment; a) solid lesions pretreatment, b) partial response after 4 months of sorafenib treatment with cavernisation and shrinkage of the lesions.Back to article page